Related to MDxHealth Awarded CLIA Certification for Irvine Laboratory

• 
• Heterodimer Immunoassay Kit
• Singulex
• The Erenna® Interleuken-17A/F (IL-17A/F) heterodimer immunoassay kit is an addition to a suite of TH17 pathway bioassays which also includes IL-17A and IL-17F as well as several others. These biomarkers are members of the IL-17 signaling pathw
• 
• Sequencing Assays
• Roche
• GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
• 
• Methylation Analysis
• Zymo Research
• The EZ DNA Methylation-Lightning kit is for complete bisulfite conversion of DNA prior to methylation analysis by PCR, MSP, array, or next-gen sequencing. The ready-to-use liquid-format Lightning conversion reagent is added directly to a DNA sample
• 
• BRAF Mutation Detection
• Swift Biosciences
• myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single-copy detection of BRAF mutations. myT BRAF-Ultra can detect less than 10 copies of mutant BRAF V600E/K with low breakthrough amplification from a backg
• 
• Microplate Detection Platform
• Molecular Devices
• The SpectraMax i3 platform’s base system features an integrated optical system enabling top and bottom reads for 6–384-well microplates and launches with three detection modes: luminescence, absorbance, and fluorescence. The user-exchangeable cartr
• 
• Knockout Cell Lines for Cancer Research
• Cellectis bioresearch
• The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
• 
• Transfection Reagent
• Mirus Bio
• TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
• 
• Protein Biomarker Immunoassays
• Olink Bioscience
• Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
• 
• Tumor Marker Control
• Randox Laboratories
• The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
• 
• Epigenetics Conjugates
• Cisbio Bioassays
• The epigenetics toolbox is a selection of conjugates specifically developed for epigenetics studies to help pharmaceutical and biotechnology researchers better understand how these events occur through epigenetic mechanisms and how they relate
• 
• Methylated Gene Targeting
• Cellectis bioresearch
• TALEN™ CpG™ is a service designed to overcome the impact of methylated DNA on TALEN nuclease activity. Users can target any gene at any position in any cell type regardless of methylation status. The service can make gene editing accessible for the
• 
• DNA Reference Standard
• Horizon Discovery
• The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds